Oramed Oral COVID-19 Vaccine Maker Gets IRB Approval for Clinical Trial
Oramed Pharmaceuticals Inc. (NASDAQ: ORMP) (TASE: ORMP) (www.oramed.com), a clinical-stage pharmaceutical company focused on the development of oral drug delivery systems, today announced several updates for its majority-owned company Oravax…
Continue Reading
Oramed Oral COVID-19 Vaccine Maker Gets IRB Approval for Clinical Trial